|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Investigation |
1 Russell H. Morgan Department of Radiology and Radiological Sciences, Division of Nuclear Medicine, Johns Hopkins University, Baltimore, Maryland; 2 Department of Oncology and Biostatistics, Johns Hopkins University, Baltimore, Maryland; and 3 Department of OtolaryngologyHead and Neck Surgery, Johns Hopkins University, Baltimore, Maryland
Correspondence: For correspondence or reprints contact: Harvey A. Ziessman, MD, Johns Hopkins Outpatient Center, 601 N. Caroline St., JHOC Room 3231, Baltimore, MD 21287. E-mail: hziessm1{at}jhmi.edu
Various methodologies for 99mTc-sestamibi parathyroid scintigraphy are in clinical use. There are few direct comparisons between the different methods and even less evidence supporting the superiority of one over another. Some reports suggest that SPECT is superior to planar imaging. The addition of CT to SPECT may further improve parathyroid adenoma localization. The purpose of our investigation was to compare hybrid SPECT/CT, SPECT, and planar imaging and to determine whether dual-phase imaging is advantageous for the 3 methodologies. Methods: Scintigraphy was performed on 110 patients with primary hyperparathyroidism and no prior neck surgery. Of these, 98 had single adenomas and are the subject of this review. Planar imaging and SPECT/CT were performed at 15 min and 2 h after injection. Six image sets (early and delayed planar imaging, SPECT, and SPECT/CT) and combinations of the 2 image sets were reviewed for adenoma localization at 13 possible sites. Each review was scored for location and certainty of focus by 2 reviewer groups. Surgical location served as the standard. Sensitivity, specificity, area under the curve, positive predictive value, negative predictive value, and
-values were determined for each method. Results: The overall
-coefficient (certainty of adenoma focus) between reading groups was 0.68 (95% confidence interval, 0.660.70). The highest values were for dual-phase studies that included SPECT/CT. Dual-phase planar imaging, SPECT, and SPECT/CT were statistically significantly superior to single-phase early or delayed imaging in sensitivity, area under the curve, and positive predictive value. Neither single-phase nor dual-phase SPECT was statistically superior to dual-phase planar imaging. Early-phase SPECT/CT in combination with any delayed imaging method was superior to dual-phase planar imaging or SPECT for sensitivity, area under the curve, and positive predictive value. Conclusion: Early SPECT/CT in combination with any delayed imaging method was statistically significantly superior to any single- or dual-phase planar or SPECT study for parathyroid adenoma localization. Localization with dual-phase acquisition was more accurate than with single-phase 99mTc-sestamibi scintigraphy for planar imaging, SPECT, and SPECT/CT.
Key Words: hyperparathyroidism parathyroid adenoma parathyroid scintigraphy SPECT/CT minimally invasive parathyroidectomy
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
M. B. Tomas, P. V. Pugliese, G. G. Tronco, C. Love, C. J. Palestro, and K. J. Nichols Pinhole Versus Parallel-Hole Collimators for Parathyroid Imaging: An Intraindividual Comparison J. Nucl. Med. Technol., December 1, 2008; 36(4): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Neumann, N. A. Obuchowski, and F. P. DiFilippo Preoperative 123I/99mTc-Sestamibi Subtraction SPECT and SPECT/CT in Primary Hyperparathyroidism J. Nucl. Med., December 1, 2008; 49(12): 2012 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Eslamy and H. A. Ziessman Parathyroid Scintigraphy in Patients with Primary Hyperparathyroidism: 99mTc Sestamibi SPECT and SPECT/CT1 RadioGraphics, September 1, 2008; 28(5): 1461 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Buck, S. Nekolla, S. Ziegler, A. Beer, B. J. Krause, K. Herrmann, K. Scheidhauer, H.-J. Wester, E. J. Rummeny, M. Schwaiger, et al. SPECT/CT J. Nucl. Med., August 1, 2008; 49(8): 1305 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bybel, R. C. Brunken, F. P. DiFilippo, D. R. Neumann, G. Wu, and M. D. Cerqueira SPECT/CT Imaging: Clinical Utility of an Emerging Technology1 RadioGraphics, July 1, 2008; 28(4): 1097 - 1113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |